Alibaba's Q4 adjusted EBITA fell 84% year-on-year while Tencent missed Q1 revenue estimates — both companies simultaneously pledging to accelerate AI capital expenditure beyond already-elevated targets, crystallizing a structural tension that is now visibly bleeding into equity valuations.
From $9/month · 7-day free trial
Already a subscriber? Log in
Subscribe for full access to all articles
Start Free Trial
DJI's Pocket 4P sold out within seconds of its June 23 launch, while Insta360's Luna faces months of backlog — a 'sweet problem' for leading brands, and demand that would have been unimaginable three years ago.
FAW-Volkswagen brought the Magotan PHEV and Tanyue LPHEV to market on June 25, 2026, priced from 169,900 yuan — below the 200,000 yuan threshold that separates the premium family car segment.
China's NMPA approved Suriqioleucel on June 22, 2026, making it the first CAR-T therapy cleared anywhere in the world for advanced end-stage gastric cancer. Priced at 990,000 RMB per dose, the drug more than doubled median survival in clinical trials, from 3.98 months to 9.17 months.